Prescription of psychotropic drugs in patients with chronic renal failure on hemodialysis

References

• Drayer RA, Piraino B, Reynolds CF 3rd, et al. Characteristics of depression in hemodialysis patients: Symptoms, quality of life and mortality risk. Gen Hosp Psychiatry. 2006;28(4):306–312
   Web of Science ®Google Scholar
• Kimmel PL, Cukor D, Cohen SD, et al. Depression in end-stage renal disease patients: A critical review. Adv Chronic Kidney Dis. 2007;14(4):328–334
   Web of Science ®Google Scholar
• Hwang SJ, Tsai JC, Chen HC. Epidemiology, impact and preventive care of chronic kidney disease in Taiwan. Nephrology (Carlton). 2010;15(Suppl 2):3–9
   PubMed Web of Science ®Google Scholar
• Hsieh RL, Lee WC, Huang HY, et al. Quality of life and its correlates in ambulatory hemodialysis patients. J Nephrol. 2007;20(6):731–738
   Google Scholar
• Chilcot J, Wellsted D, Da Silva-Gane M, et al. Depression on dialysis. Nephron Clin Pract. 2008;108(4):c256–c264
   Google Scholar
• Hedayati SS, Finkelstein FO. Epidemiology, diagnosis, and management of depression in patients with CKD. Am J Kidney Dis. 2009;54(4):741–752
   PubMed Web of Science ®Google Scholar
• Zalai D, Szeifert L, Novak M. Psychological distress and depression in patients with chronic kidney disease. Semin Dial. 2012;25(4):428–438
   Web of Science ®Google Scholar
• Halen NV, Cukor D, Constantiner M, et al. Depression and mortality in end-stage renal disease. Curr Psychiatr Rep. 2012;14(1):36–44
   PubMed Web of Science ®Google Scholar
• Hedayati SS, Yalamanchili V, Finkelstein FO. A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease. Kidney Int. 2012;81(3):247–255
   PubMed Web of Science ®Google Scholar
• Cohen SD, Norris L, Acquaviva K, et al. Screening, diagnosis, and treatment of depression in patients with end-stage renal disease. Clin J Am Soc Nephrol. 2007;2(6):1332–1342
   PubMed Web of Science ®Google Scholar
• Levy NB. Use of psychotropics in patients with kidney failure. Psychotropics. 1985;26:699–709
   Google Scholar
• Raymond CB, Wazny LD, Honcharik PL. Pharmacotherapeutic options for the treatment of depression in patients with chronic kidney disease. Nephrol Nurs J. 2008;35(3):257–263
   Google Scholar
• Nagler EV, Webster AC, Vanholder R, et al. Antidepressants for depression in stage 3–5 chronic kidney disease: A systematic review of pharmacokinetics, efficacy and safety with recommendations by European Renal Best Practice (ERBP). Nephrol Dial Transplant. 2012;27(10):3736–3745
   Google Scholar
• Tsai CJ, Loh el W, Lin CH, et al. Correlation of antidepressive agents and the mortality of end-stage renal disease. Nephrology (Carlton). 2012;17(4):390–397
   Google Scholar
• Wyne A, Rai R, Cuerden M, et al. Opioid and benzodiazepine use in end-stage renal disease: A systematic review. Clin J Am Soc Nephrol. 2011;6(2):326–333
   Google Scholar
• Fukuhara S, Green J, Albert J, et al. Symptoms of depression, prescription of benzodiazepines, and the risk of death in hemodialysis patients in Japan. Kidney Int. 2006;70(10):1866–1872
   Google Scholar
• Winkelmayer WC, Mehta J, Wang PS. Benzodiazepine use and mortality of incident dialysis patients in the United States. Kidney Int. 2007;72:1388–1393
   Google Scholar
• Chen CK, Tsai YC, Hsu HJ, et al. Depression and suicide risk in hemodialysis patients with chronic renal failure. Psychosomatics. 2010;51(6):528.e1–528.e6
   Google Scholar
• Wang LJ, Wu MS, Hsu HJ, et al. The relationship between psychological factors, inflammation, and nutrition in patients with chronic renal failure undergoing hemodialysis. Int J Psychiatry Med. 2012;44(2):105–118
   Google Scholar
• Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatr. 1998;59(Suppl 20):22–33; quiz 34–57
   PubMed Web of Science ®Google Scholar
• Kuo CJ, Tang HS, Tsay CJ, et al. Prevalence of psychiatric disorders among bereaved survivors of a disastrous earthquake in taiwan. Psychiatr Serv. 2003;54(2):249–251
   PubMed Web of Science ®Google Scholar
• Olsson I, Mykletun A, Dahl AA. The Hospital Anxiety and Depression Rating Scale: A cross-sectional study of psychometrics and case finding abilities in general practice. BMC Psychiatry. 2005;5:46
   PubMed Web of Science ®Google Scholar
• Loosman WL, Siegert CE, Korzec A, et al. Validity of the Hospital Anxiety and Depression Scale and the Beck Depression Inventory for use in end-stage renal disease patients. Br J Clin Psychol. 2010;49(Pt 4):507–516
   Google Scholar
• Leung CM, Wing YK, Kwong PK, et al. Validation of the Chinese-Cantonese version of the hospital anxiety and depression scale and comparison with the Hamilton Rating Scale of Depression. Acta Psychiatr Scand. 1999;100(6):456–461
   PubMed Web of Science ®Google Scholar
• Chalder T, Berelowitz G, Pawlikowska T, et al. Development of a fatigue scale. J Psychosom Res. 1993;37(2):147–153
   PubMed Web of Science ®Google Scholar
• Wong WS, Fielding R. Construct validity of the Chinese version of the Chalder Fatigue Scale in a Chinese community sample. J Psychosom Res. 2010;68(1):89–93
   Google Scholar
• Ware JE, Jr Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30(6):473–483
   PubMed Web of Science ®Google Scholar
• Johnson S, Dwyer A. Patient perceived barriers to treatment of depression and anxiety in hemodialysis patients. Clin Nephrol. 2008;69(3):201–206
   Web of Science ®Google Scholar
• Raymond CB, Wazny LD, Honcharik PL. Pharmacotherapeutic options for the treatment of depression in patients with chronic kidney disease. Nephrol Nurs J. 2008;35(3):257–263; quiz 264
   Google Scholar
• Tossani E, Cassano P, Fava M. Depression and renal disease. Semin Dial. 2005;18(2):73–81
   Google Scholar
• Farrokhi F. Depression among dialysis patients: Barriers to good care. Iran J Kidney Dis. 2012;6(6):403–406
   Google Scholar
• Watnick S, Kirwin P, Mahnensmith R, et al. The prevalence and treatment of depression among patients starting dialysis. Am J Kidney Dis. 2003;41(1):105–110
   PubMed Web of Science ®Google Scholar
• Hedayati SS, Bosworth HB, Kuchibhatla M, et al. The predictive value of self-report scales compared with physician diagnosis of depression in hemodialysis patients. Kidney Int. 2006;69(9):1662–1668
   Google Scholar
• Kalender B, Ozdemir AC, Yalug I, et al. Antidepressant treatment increases quality of life in patients with chronic renal failure. Ren Fail. 2007;29(7):817–822
   PubMed Web of Science ®Google Scholar
• Hosseini SH, Espahbodi F, Mirzadeh Goudarzi SM. Citalopram versus psychological training for depression and anxiety symptoms in hemodialysis patients. Iran J Kidney Dis. 2012;6(6):446–451
   Google Scholar
• Levy NB. What is psychonephrology? J Nephrol. 2008;21(Suppl 13):S51–S53
   PubMedGoogle Scholar
• Cukor D, Coplan J, Brown C, et al. Depression and anxiety in urban hemodialysis patients. Clin J Am Soc Nephrol. 2007;2(3):484–490
   PubMed Web of Science ®Google Scholar
• Fukunishi I, Kitaoka T, Shirai T, Kino K, Kanematsu E, Sato Y. Delirium in patients on hemodialysis therapy. Nephron. 2002;90(2):236
   Google Scholar
• Owen S. Surman LMP. Organ failure and transplantation. In: Theodore A, Stern GLF, Ned HC, Michael SJ, Jerrold FR, eds. Massachusetts General Hospital Handbook of General Hospital Psychiary. 6th ed. Philadelphia: Saunders Elsevier; 2010:337–351
   Google Scholar
• Kring DL, Crane PB. Factors affecting quality of life in persons on hemodialysis. Nephrol Nurs J. 2009;36(1):15–24, 55
   Google Scholar